Autism drug advances to late-stage clinical trials - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 883total visits
Autism drug advances to late-stage clinical trials - Related Stories - AAP SmartBrief
Seaside Therapeutics will proceed with late-stage trials of drug candidate STX209 for fragile X syndrome and autism spectrum disorder. The move comes after a second Phase II study showed that the treatment significantly improved symptoms of autism spectrum disorder in patients ages 6 to 17. The fir--
View full resource at smartbrief.com
Tags: Genetic, Fragile X, Autism Spectrum Disorder, Autism, Drug, Clinical Trial, American Academy of Pediatrics
Most Recently Shared on September 10, 2010 at 6:44 pm By:
Autism drug advances to late-stage clinical trials http://sbne.ws/r/5D0l
Advertisement
